🇺🇸 FDA
Pipeline program

PG-011 nasal spray 0.6%(twice daily)

PG-011-SAR-301(phase III)

Phase 3 small_molecule active

Quick answer

PG-011 nasal spray 0.6%(twice daily) for Seasonal Allergic Rhinitis is a Phase 3 program (small_molecule) at Prime Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Prime Medicine
Indication
Seasonal Allergic Rhinitis
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials